4//SEC Filing
Novus Therapeutics, Inc. 4
Accession 0000899243-17-012930
$ELDNCIK 0001404281operating
Filed
May 10, 8:00 PM ET
Accepted
May 11, 8:30 PM ET
Size
4.8 KB
Accession
0000899243-17-012930
Insider Transaction Report
Form 4
OCAMPO CHRISTINE
See Remarks
Transactions
- Purchase
Common Stock
2017-05-10$9.99/sh+10,010$100,000→ 21,590 total
Footnotes (1)
- [F1]All numbers give effect to the 1:9 reverse stock split effected by the Company on May 11, 2017.
Documents
Issuer
Novus Therapeutics, Inc.
CIK 0001404281
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001404281
Filing Metadata
- Form type
- 4
- Filed
- May 10, 8:00 PM ET
- Accepted
- May 11, 8:30 PM ET
- Size
- 4.8 KB